 |
Terns Pharmaceuticals
Last updated: September 15, 2024
CEO Senthil Sundaram
USA | Funding: $498.5M (+)
Website: https://ternspharma.com/
Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global nonalcoholic steatohepatitis (NASH) burden.
Website: https://ternspharma.com/
Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global nonalcoholic steatohepatitis (NASH) burden.
